tiprankstipranks
Tyra Biosciences granted IND clearance from FDA for Phase 2 study of Tyra-300
PremiumThe FlyTyra Biosciences granted IND clearance from FDA for Phase 2 study of Tyra-300
2M ago
Tyra Biosciences price target raised to $32 from $30 at H.C. Wainwright
Premium
The Fly
Tyra Biosciences price target raised to $32 from $30 at H.C. Wainwright
2M ago
Judge blocks Tapestry-Capri deal, Centene reports Q3 beat: Morning Buzz
Premium
The Fly
Judge blocks Tapestry-Capri deal, Centene reports Q3 beat: Morning Buzz
2M ago
Tyra Biosciences management to meet virtually with Piper Sandler
PremiumThe FlyTyra Biosciences management to meet virtually with Piper Sandler
3M ago
Tyra Biosciences price target raised to $33 from $25 at Oppenheimer
Premium
The Fly
Tyra Biosciences price target raised to $33 from $25 at Oppenheimer
3M ago
Tyra Biosciences management to meet with Oppenheimer
Premium
The Fly
Tyra Biosciences management to meet with Oppenheimer
3M ago
Tyra Biosciences price target lowered to $25 from $28 at Oppenheimer
PremiumThe FlyTyra Biosciences price target lowered to $25 from $28 at Oppenheimer
5M ago
Tyra Biosciences price target raised to $25 from $23 at H.C. Wainwright
Premium
The Fly
Tyra Biosciences price target raised to $25 from $23 at H.C. Wainwright
5M ago
Tyra Biosciences reports Q2 EPS (32c), consensus (41c)
Premium
The Fly
Tyra Biosciences reports Q2 EPS (32c), consensus (41c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100